Osaka, Japan – February 15, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approvals by the Ministry of Health, Labour and Welfare for eight molecules in 19 ... Read More
Awardees Recognized for Excellence in Innovation
Maple Grove, MN – February 12, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are proud to honor the 2017 NASPA Excellence in Innovation ... Read More
Bumetanide Tablets, USP 0.5 mg, 1 mg, and 2 mg Upsher-Smith Laboratories, LLC
Maple Grove, MN – January 30, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has received U.S. Food and Drug Administration (FDA) ... Read More
Maple Grove, MN – January 5, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today reported that on January 3, 2018, its parent company, Japan-based Sawai Pharmaceutical Co., Ltd. (Sawai) successfully completed the sale of a 20 percent ... Read More
Maple Grove, MN – November 29, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be exhibiting at the 71st Annual Meeting of the American Epilepsy Society (AES), December 1-5, 2017, in Washington, ... Read More
Maple Grove, MN – November 28, 2017 – Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON® Powder (Potassium Chloride) for oral solution, 20 mEq. The Company received approval of an abbreviated new drug ... Read More
Maple Grove, MN – November 14, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the 2017 Scottsdale Headache Symposium®, November 16-19, 2017 in Phoenix, AZ. Upsher-Smith representatives will be available ... Read More
Maple Grove, MN – November 13, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today reported that its parent company, Japan-based Sawai Pharmaceutical Co., Ltd. (Sawai) will sell a 20 percent stake in its US subsidiary (Sawai ... Read More
Sawai Pharmaceutical Adds Zomig® (zolmitriptan) to Growing Product Portfolio
Maple Grove, MN – October 30, 2017 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today reported that its parent company, Japan-based Sawai Pharmaceutical Co., Ltd. (Sawai) has entered into ... Read More
